Leadership

Novartis president, development and chief medical officer talks about the pivotal role of the development India hub in progressing breakthrough drugs, how AI is delivering gains in the trials arena, driving focus in the R&D engine and the Swiss group’s approach in the obesity space.

Cosette Pharmaceuticals has made two key executive appointments as it looks to build up its business. Meanwhile, Canada’s CGPA has named a chair and vice-chair, and Chanelle and Neuraxpharm have announced their own executive changes.

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Jim Jones, the head of the FDA's food programs, resigned due to widespread layoffs at the agency imposed by the Trump administration’s Department of Government Efficiency.

Jim Jones resigna due to widespread layoffs at the agency the Trump administration’s Department of Government Efficiency imposed.

"While we mourn his passing, we also celebrate his remarkable legacy, which will continue to shape AHPA and the broader industry for years to come,” AHPA says.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

McCaffrey Brands makes protein bar play; singer Meghan Trainor partners with Terra Origin on line extension; USANA’s new science chief has experience with Amway; Optimum Nutrition optimizes female athletes’ commitment; Kerry Group names commercial and North America chiefs; Cizzle Brands has advisors for launch; Tosi moves on from founders with Series B funding; and first PLT Health Solutions president not from founding family.

CEO Christopher Viehbacher has said repeatedly that Biogen will build its pipeline internally and through deals, and Grogan reshuffled the research organization with that in mind.

This is Part 1 of a 2-part profile of Hans Clevers, Head of Pharma Research and Early Development at Roche.